The imaging of insulinomas using a radionuclide-labelled molecule of the GLP-1 analogue liraglutide: A new application of liraglutide

6Citations
Citations of this article
21Readers
Mendeley users who have this article in their library.

Abstract

Objective: This study explores a new, non-invasive imaging method for the specific diagnosis of insulinoma by providing an initial investigation of the use of 125I-labelled molecules of the glucagon-like peptide-1 (GLP-1) analogue liraglutide for in vivo and in vitro small-animal SPECT/CT (single-photon emission computed tomography/computed tomography) imaging of insulinomas. Methods: Liraglutide was labelled with 125I by the Iodogen method. The labelled 125I-liraglutide compound and insulinoma cells from the INS-1 cell line were then used for in vitro saturation and competitive binding experiments. In addition, in a nude mouse model, the use of 125I-liraglutide for the in vivo small-animal SPECT/CT imaging of insulinomas and the resulting distribution of radioactivity across various organs were examined. Results: The labelling of liraglutide with 125I was successful, yielding a labelling rate of approximately 95% and a radiochemical purity of greater than 95%. For the binding between 125I-liraglutide and the GLP-1 receptor on the surface of INS-1 cells, the equilibrium dissociation constant (Kd) was 128.8±30.4 nmol/L(N = 3), and the half-inhibition concentration (IC 50) was 542.4±187.5 nmol/L(N = 3). Small-animal SPECT/CT imaging with 125I-liraglutide indicated that the tumour imaging was clearest at 90 min after the 125I-liraglutide treatment. An examination of the in vivo distribution of radioactivity revealed that at 90 min after the 125I-liraglutide treatment, the target/non-target (T/NT) ratio for tumour and muscle tissue was 4.83±1.30(N = 3). Our study suggested that 125I-liraglutide was predominantly metabolised and cleared by the liver and kidneys. Conclusion: The radionuclide 125I-liraglutide can be utilised for the specific imaging of insulinomas, representing a new noninvasive approach for the in vivo diagnosis of insulinomas. © 2014 Lv et al.

Cite

CITATION STYLE

APA

Lv, J., Pan, Y., Li, X., Cheng, D., Liu, S., Shi, H., & Zhang, Y. (2014). The imaging of insulinomas using a radionuclide-labelled molecule of the GLP-1 analogue liraglutide: A new application of liraglutide. PLoS ONE, 9(5). https://doi.org/10.1371/journal.pone.0096833

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free